Navigation Links
Sinovac Appoints Kenneth Lee to Board of Directors
Date:5/31/2011

BEIJING, May 31, 2011 /PRNewswire-Asia/ -- Sinovac Biotech Ltd. (NASDAQ: SVA), a leading provider of biopharmaceutical products in China, announced today the appointment of Mr. Kenneth Lee as a director to the Board of the Company effective on May 31, 2011 to replace Mr. Xianping Wang who resigned from the Board due to personal reasons.

Kenneth Lee is a Principal at SAIF Partners, a leading growth capital fund focused on China and India.  He brings more than 15 years of experience across private equity investment, corporate finance, and business development in China to Sinovac.  Before becoming a member of the SAIF team in 2007, Mr. Lee previously was with Topsec Holdings, RimAsia Capital Partners, Delta Associates – the exclusive advisor to Asia Equity Infrastructure Fund, CNK Telecom, H&Q Asia Pacific, and Salomon Brothers in New York.  Mr. Lee is a graduate of Amherst College.

Dr. Weidong Yin, Chairman and CEO said: "We are pleased to invite Kenneth Lee to our Board. Given his wealth of experience in corporate finance and business development in China, I believe he will bring new perspectives and insights to our Board in the interest of the Company and shareholders. I look forward to the contributions he will make to our Company."

About SinovacSinovac Biotech Ltd. is a China-based biopharmaceutical company that focuses on the research, development, manufacture and commercialization of vaccines that protect against human infectious diseases including hepatitis A, seasonal influenza, H5N1 (bird flu) pandemic influenza and H1N1 influenza. In 2009, Sinovac was the first company worldwide to receive approval for its H1N1 influenza vaccine, PANFLU.1, and has received the orders from the Chinese Central Government pursuit to the government stockpiling program. The Company is developing a number of new vaccine products, including vaccines
'/>"/>

SOURCE Sinovac Biotech Ltd.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Sinovac Commences Vaccination on Volunteers for Phase II Clinical Trial on Pandemic Influenza H5N1 Vaccine
2. Sinovac Provides Update in Pandemic Influenza Vaccines (H5N1) Phase II Clinical Trials
3. Sinovac Initiates Phase II Volunteer Enrollment for Split Viron Pandemic Influenza (H5N1) Vaccine
4. Sinovac Announces Plan to Launch Offering of Common Shares
5. Sinovac Announces Recent Developments
6. Sinovac Obtains Fifth H1N1 Vaccine Order from Chinese Central Government
7. Sinovac Receives Purchase Order from Shanghai Government to Supply Hepatitis A Vaccine Healive(R)
8. Sinovacs PANFLU.1 (H1N1) Regulatory Approval Expanded to Include Geriatric Population
9. Sinovac Files Shelf Registration Statement
10. Sinovac Named One of Chinas Top 10 Most Competitive Companies Listed Overseas in 2009
11. Sinovacs CEO Weidong Yin Nominated for China Central Televisions Prestigious Economic Man-of-the-Year Award
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/21/2015)... , April 21, 2015  Perrigo Company plc ... its Board of Directors has unanimously rejected the unsolicited ... MYL ), disclosed April 8, 2015, to acquire all ... share. Following a thorough review, advised by its financial ... Proposal substantially undervalues the Company and its future growth ...
(Date:4/21/2015)... , 21. April 2015  CorTechs Labs, ... quantitative Analyse des Hirnvolumens freut sich, eine ... Pharmaunternehmen, bekannt geben zu können. Die Unternehmen ... des Hirnvolumens zusammenarbeiten, der die Identifizierung, Messung ... Patienten mit multipler Sklerose als Ziel hat. ...
(Date:4/21/2015)... WASHINGTON , April 21, 2015 ... the National Minority Quality Forum (NMQF), today ... president of the Pharmaceutical Research and Manufacturers of ... diversity in clinical trials. On behalf of PhRMA, and ... In " campaign to build awareness, start conversations, and ...
Breaking Medicine Technology:Perrigo Board Unanimously Rejects Unsolicited Proposal From Mylan 2Perrigo Board Unanimously Rejects Unsolicited Proposal From Mylan 3Perrigo Board Unanimously Rejects Unsolicited Proposal From Mylan 4Perrigo Board Unanimously Rejects Unsolicited Proposal From Mylan 5Perrigo Board Unanimously Rejects Unsolicited Proposal From Mylan 6Perrigo Board Unanimously Rejects Unsolicited Proposal From Mylan 7Perrigo Board Unanimously Rejects Unsolicited Proposal From Mylan 8Perrigo Board Unanimously Rejects Unsolicited Proposal From Mylan 9CorTechs Labs kündigt Partnerschaft für die Bereitstellung umfassender Lösungen zur Quantifizierung des Verlustes von Hirnvolumen bei multipler Sklerose an 2National Minority Quality Forum to Award PhRMA President John Castellani for Leadership in Increasing Clinical Trial Diversity 2National Minority Quality Forum to Award PhRMA President John Castellani for Leadership in Increasing Clinical Trial Diversity 3
... 18 Misonix, Inc. (Nasdaq: MSON ), ... device technology, which worldwide is used for acute health ... Organization ("GPO") Agreement with First Choice Cooperative ("FCC"), headquartered ... Misonix will offer FCC members the opportunity to purchase ...
... Medical, Inc. (OTC Bulletin Board: AEMD ), ... infectious disease and cancer, today announced that it has ... to expand the opportunity for Aethlon to commercialize its ... centers in India.  The therapeutic focus at each center ...
Cached Medicine Technology:Misonix Announces New GPO Agreement With First Choice Cooperative 2Misonix Announces New GPO Agreement With First Choice Cooperative 3Aethlon Medical Announces Expansion of Hepatitis C Virus (HCV) Treatment Programs 2Aethlon Medical Announces Expansion of Hepatitis C Virus (HCV) Treatment Programs 3Aethlon Medical Announces Expansion of Hepatitis C Virus (HCV) Treatment Programs 4Aethlon Medical Announces Expansion of Hepatitis C Virus (HCV) Treatment Programs 5
(Date:4/21/2015)... 2015 On April 2, 2015, Elle ... Achieve Kylie Jenner Lips With Disastrous Results,” ... themselves while attempting an at-home lip augmentation ... that creating an airlock around one’s mouth for several ... and achieve Kylie Jenner’s now famous pout. (see: goo.gl/dFQW2L) ...
(Date:4/21/2015)... April 21, 2015 “ ZeroWire ” ... Tech Report, which takes a look at the latest ... Scott Steinberg, a special reporter for NewsWatch and a ... how ZeroWire is a security system and lifestyle management ... there were over 2 million burglaries in 2010. It ...
(Date:4/21/2015)... Lewisville, TX (PRWEB) April 21, 2015 ... (NYSE:ADPT) announced today it is opening its first freestanding ... located in Chandler, Arizona and will be licensed under ... of the Dignity Health and Adeptus Health joint venture. ... Chandler Regional and Mercy Gilbert Medical Centers said the ...
(Date:4/21/2015)... 2015 Wireless Analytics, LLC , ... recognized by the Boston Business Journal as the 25th ... announced at a recent event celebrating the 2015 ... fastest-growing private companies in Massachusetts. , Wireless Analytics was ... that recorded the fastest revenue growth from 2011 through ...
(Date:4/21/2015)... (PRWEB) April 21, 2015 ... 2015” provides comparative analysis on the therapeutic ... R&D pipelines by identifying new targets and ... Complete report with TOC is available @ ... also reviews key players involved in the ...
Breaking Medicine News(10 mins):Health News:Celebrity Cosmetic Surgeon Comments on Report of Teen Girls Injuring Themselves Attempting Kylie Jenner-Inspired Twitter Challenge 2Health News:A Leader in Home Security was Featured on NewsWatch Television 2Health News:Dignity Health and Adeptus Health to Open First Freestanding Emergency Room in Chandler, Arizona 2Health News:Dignity Health and Adeptus Health to Open First Freestanding Emergency Room in Chandler, Arizona 3Health News:Wireless Analytics Ranked as 25th Fastest Growing Private Company in Massachusetts 2Health News:Dermatitis Therapeutic Development and Pipeline Market Review H1 2015 Available at RnRMarketResearch.com 2Health News:Dermatitis Therapeutic Development and Pipeline Market Review H1 2015 Available at RnRMarketResearch.com 3Health News:Dermatitis Therapeutic Development and Pipeline Market Review H1 2015 Available at RnRMarketResearch.com 4
... Kids seem to be ignoring message that methamphetamine is ... anti-methamphetamine campaign that utilizes graphic images actually may not ... Montana Meth Project (MMP), created in 2005, featured images ... once." The perceived success of the program had resulted ...
... RALEIGH, N.C., Dec. 11 PRA International, a ... new office in,Mexico City, Mexico. With years ... market in 2005. The region,s existing base ... and infectious diseases,match favorably to PRA,s therapeutic focus. ...
... Drive China,s Psychiatric Drug Market to Reach Nearly $1 Billion ... , , WALTHAM, Mass., Dec. ... and advisory firms focusing on pharmaceutical and healthcare issues, finds ... remain. According to the new special Emerging Markets report entitled ...
... Cytometer System Twice Yearly to Support Innovative Research and Expand ... -Learn More about the Revolutionary Accuri C6 Flow ... , , ANN ARBOR, Mich., ... developing revolutionary bench-top flow cytometer systems, today announced the first ...
... Puppies , , RHINELANDER, Wis., Dec. ... Joshua Tree, California, has been an avid animal lover, trainer and ... Gene,s first dog was no exception. He would have to give ... began Gene,s life long passion for breeding and training animals. ...
... Access to Renal Function and MetLyte 8 Panels for ... UNION CITY, Calif., Dec. 11 Abaxis, Inc. (Nasdaq: ... point-of-care blood analysis systems, today announced that the U.S. ... under CLIA regulations for two additional analytes, Creatine Kinase ...
Cached Medicine News:Health News:Study Questions Value of Anti-Meth Campaign 2Health News:PRA International Expands Operations in Mexico 2Health News:China's Views on Mental Disorders Improving but Challenges Remain 2Health News:China's Views on Mental Disorders Improving but Challenges Remain 3Health News:Researcher Receives Free C6 Flow Cytometer(R) System as First Winner of Accuri Flow Cytometer(R) Creativity Awards Program 2Health News:Researcher Receives Free C6 Flow Cytometer(R) System as First Winner of Accuri Flow Cytometer(R) Creativity Awards Program 3Health News:Researcher Receives Free C6 Flow Cytometer(R) System as First Winner of Accuri Flow Cytometer(R) Creativity Awards Program 4Health News:20,000,000th Phone Order Placed at Doctors Foster & Smith Pet Supplies 2Health News:Abaxis Point-of-Care Test Panels Gain FDA CLIA-Waived Status 2Health News:Abaxis Point-of-Care Test Panels Gain FDA CLIA-Waived Status 3Health News:Abaxis Point-of-Care Test Panels Gain FDA CLIA-Waived Status 4
Used for the introduction of catheters, balloons and other vascular devices....
Used to introduce balloon, electrode, closed or non-tapered end catheters and other devices for intervention....
Used for contralateral access to the iliac artery for interventional procedures after initial wire guide positioning has been established....
Used to introduce balloon, electrode, closed or non-tapered end and other catheters....
Medicine Products: